Related by context. Frequent words. (Click for all words.) 74 metastatic colorectal 73 refractory chronic lymphocytic 72 recurrent glioblastoma multiforme 72 metastatic castrate resistant 71 breast pancreatic 70 lung pancreatic 70 ThermoDox R 70 gemcitabine chemotherapy 70 unresectable locally advanced 70 metastatic castration resistant 69 HER2 positive metastatic breast 69 colorectal lung 69 pancreatic adenocarcinoma 68 advanced unresectable 67 colorectal carcinoma 67 R sorafenib tablets 67 metastatic hormone refractory 67 VEGFR2 inhibitor 67 non squamous 67 unresectable 67 EGFR expressing metastatic colorectal 67 histologically confirmed 67 TTR amyloidosis 67 oral deforolimus 66 clinically localized prostate 66 ovarian breast 66 Meets Primary Endpoint 66 pertuzumab 66 recurrent glioblastoma 66 lymphoma leukemia 65 Metastatic Melanoma 65 Endometrial 65 Panzem R NCD 65 EFAPROXYN 65 hepatocellular cancer 65 opioid induced constipation OIC 65 plus prednisone 65 malignant pleural mesothelioma 65 metastatic liver 65 lymphoma CTCL 65 prostate pancreatic 65 cell acute lymphoblastic 65 castrate resistant prostate cancer 65 carboplatin paclitaxel 65 Vandetanib 65 Genasense ® 65 Initiates Phase II 65 FOLFOX4 64 Irinotecan 64 Proxinium TM 64 metastatic bone 64 forodesine 64 multiple myeloma MM 64 Daclizumab 64 J Am Coll 64 plus gemcitabine 64 advanced adenomas 64 Panzem R 64 EGFR expressing mCRC 64 Receives Orphan Drug Designation 64 relapsed refractory multiple myeloma 64 AEG# 64 Romidepsin 64 2 methoxyestradiol 64 sunitinib malate 64 KRAS wild 64 mCRC patients 64 metastatic renal cell carcinoma 63 nonsmall cell lung cancer 63 pegylated interferon alfa 2a 63 mRCC 63 murine model 63 gastrointestinal mucositis 63 Amrubicin 63 distant metastasis 63 receiving VELCADE 63 locoregional 63 huC# DM4 63 Phase Ib II 63 histone deacetylase HDAC inhibitor 63 advanced carcinoid 63 Secondary endpoints included 63 phase IIb clinical 63 resectable 63 gastrointestinal stromal tumors GIST 63 ALN TTR 63 cervical breast 63 neoadjuvant chemotherapy 63 Idiopathic Pulmonary Fibrosis 63 HGS ETR2 63 HGS ETR1 63 prostate colon 63 cutaneous melanoma 63 myeloproliferative disorders 63 Completes Enrollment 63 leukemia CLL 63 Metastatic 63 hepatocellular carcinoma HCC 63 bladder cancers 63 Pivotal Phase III 63 Improves Survival